Top Abstract Purchase Related
Home
>
Node
>
Subnode

An autopsy report of graft-versus-host disease (GVHD) following blood transfusion

Otori, K.; Masuda, C.; Wanibuchi, H.; Nakanishi, A.; Kawabata, K.; Ohashi, H.; Fukushima, S.

Osaka City Medical Journal 45(1): 37-43

1999

ISSN/ISBN: 0030-6096
PMID: 10723200
Document Number: 498115
A case of graft-versus-host disease (GVHD) associated with blood transfusion in a 71-year-old man is reported. The patient received transfusions (irradiation red cells M.A.P 14 units, fresh frozen plasma 11 units) and developed features of GVHD including fever, a skin rash, diarrhea, liver dysfunction, hypoplastic bone marrow, and pancytopenia. He died on day 32 posttransfusion. Pathologically, lymphocyte infiltration of skin and liver lesions, degeneration of small bile ducts, crypt cell necrosis in the gastrointestinal tract, and bone marrow hypoplasia were observed. Immunohistochemically, infiltrating lymphocytes were CD8+ T type, the result suggesting that they role a part in posttransfusion GVHD.

Document emailed within 1 workday
Secure & encrypted payments

Wall, D.A.; Hamberg, S.; Ferrara, J.L.; Abbas, A.K. 1989: Immunodeficiency in graft-versus-host disease (GVHD). II. Effects of GVHD-induced suppressor cells on CD4+ T cell clones Journal of Immunology 143(1): 74-78
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Kolb, H.J.; Wundisch, G.F.; Bender, C.; Rodt, H.; Thiel, E.; Grosse-Wilde, H.; Thierfelder, S. 1978: Chronic graft-versus-host disease (GVHD) Pathologie-Biologie 26(1): 52
Tanaka, S. 1997: Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2277-2281
Park, B.H.; Good, R.A.; Gate, J.; Burke, B. 1974: Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease Transplantation Proceedings 6(4): 385-387
Acosta, A.; Infante, J.F.; Sarmiento, M.E.; Izquierdo, L.; Capó, V.; Dueñas, P.; Zamanillo, T.; Sierra, G. 1994: Sequential study of an experimental model of graft vs. host disease (GvHD) in non-immunosuppressed F1 (CBA/J x C57BL/6) mice Archives of Medical Research 25(2): 155-157
De Ruysscher, D.; Sobis, H.; Vandeputte, M.; Waer, M. 1991: A subpopulation of asialo GM1-positive cells plays a protective role in the occurrence of graft-versus-host disease (GVHD) in mice Transplantation Proceedings 23(1 Part 1): 804
Sun, J.; Johnston, B.; Jung, S.E.; Waring, M.; Horvat, M.; Sheil, A.G. 1996: Cross-species chimerism and graft-versus-host disease (GVHD) induced by transplantation of mouse fetal hematopoietic cells into newborn rats Transplantation Proceedings 28(2): 663-664
Bojanić, I.; Cepulić, B.G.ć 2004: Transfusion-associated graft-versus-host disease Lijecnicki Vjesnik 126(1-2): 39-47
Gupta, A.; Bansal, D.; Dass, R.; Das, A. 2004: Transfusion associated graft versus host disease Indian Pediatrics 41(12): 1260-1264
Gössi, U.; Bucher, U.; Brun del Re, G.; Miloni, E.; Hess, T. 1985: Acute graft-versus-host disease following a single transfusion of erythrocytes Schweizerische Medizinische Wochenschrift 115(2): 34-40
Sebnem Kilic, S.; Kavurt, S.; Balaban Adim, S. 2010: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency Journal of Investigational Allergology and Clinical Immunology 20(2): 153-156
Hovdenes, J.; Solheim, B.G. 1995: Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(12): 1499-1501
de Gast, G.C.; Beatty, P.G.; Amos, D.; Sullivan, K.; Anderson, J.E.; Thomas, E.D.; Hansen, J.A. 1987: Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation Transplantation Proceedings 19(1 Pt 3): 2700
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Pals, S.T.; Radaszkiewicz, T.; Gleichmann, E. 1984: Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD Journal of Immunology 132(4): 1669-1678
Nishimura, M.; Hidaka, N.; Akaza, T.; Tadokoro, K.; Juji, T. 1998: Differential effect of azidothymidine on resting and activated cells: potentiality of this drug for treatment of post-transfusion graft-versus-host disease Research Communications in Molecular Pathology and Pharmacology 100(2): 131-138